Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Expert Opinion on Biological Therapy|May 5, 2016
Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicleYana Dekempeneer, Marleen Keyaerts, Ahmet Krasniqi, et al.Journal of Nanobiotechnology|December 19, 2024
Development and evaluation of a single domain antibody targeting folate receptor alpha for radioligand therapyJonatan Dewulf, Sam Massa, Laurent Navarro, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 12, 2024
Optimizing the Therapeutic Index of sdAb-Based Radiopharmaceuticals Using PretargetingSophie Poty, Laura Ordas, Yana Dekempeneer, et al.Molecular Pharmaceutics|July 4, 2019
Labeling of Anti-HER2 Nanobodies with Astatine-211: Optimization and the Effect of Different Coupling Reagents on Their in Vivo BehaviorYana Dekempeneer, Tom Bäck, Emma Aneheim, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 2023
Preclinical Evaluation of a Radiotheranostic Single-Domain Antibody Against Fibroblast Activation Protein αYana Dekempeneer, Sam Massa, Francis Santens, et al.Molecular Cancer Therapeutics|September 21, 2022
Preclinical Evaluation of 225Ac-Labeled Single-Domain Antibody for the Treatment of HER2pos CancerMagdalena Rodak, Yana Dekempeneer, Maria Wojewódzka, et al.Molecular Pharmaceutics|August 14, 2020
Therapeutic Efficacy of <sup>213</sup>Bi-labeled sdAbs in a Preclinical Model of Ovarian CancerYana Dekempeneer, Vicky Caveliers, Maarten Ooms, et al.Cancers|April 25, 2020
Preclinical Targeted α- and β<sup>-</sup>-Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain AntibodiesJanik Puttemans, Yana Dekempeneer, Jos L Eersels, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 13, 2023
Targeted α-Therapy Using <sup>225</sup>Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor MicroenvironmentThomas Ertveldt, Ahmet Krasniqi, Hannelore Ceuppens, et al.Pageof 1